BPC-157
A recovery peptide with far more discussion than proof — offered with the evidence stated plainly.
- Explored for soft-tissue and recovery support
- Explored for the gut lining, where most of the preclinical work sits
- Considered alongside training, sleep and protein rather than instead of them
Explored, not established. Almost all of the published BPC-157 research is preclinical, and individual response varies. Nothing here is a promise of a result.
Pricing confirmed after eligibility · prescription treatment
What BPC-157 is
BPC-157 is a synthetic peptide based on a sequence identified in gastric juice, which is where the name — body protection compound — comes from. It is studied for a role in tissue repair and in the gut lining. It is prepared by a licensed compounding pharmacy under a prescription written for you; it is not an FDA-approved product and is not equivalent to or interchangeable with any branded medication.
How it works here
Every plan follows one path. Each step feeds the next. See the Peptide Therapy approach.
- 01
Measure
We baseline your labs, history, and goals.
- 02
Plan
A clinician decides whether this fits — and what else might serve you.
- 03
Act
If appropriate, you start with clear guidance and high-touch support.
- 04
Track
We monitor how you respond on a defined cadence.
- 05
Adjust
Protocols are refined over time. Guided care, not a kit in the mail.
Delivery
A compounded preparation, dispensed by a licensed pharmacy on an individual prescription. How it is taken, and for how long, is set by the prescribing clinician after a review.
Is it right for you?
Adults over 45 recovering from soft-tissue injury or carrying a training load their recovery no longer matches, who have had the obvious causes looked at first, and who want the evidence described honestly rather than sold. See peptide therapy for how these are used here.
Often considered alongside
Wolverine Stack
CompoundedTwo recovery peptides used together, with the gap in the evidence stated rather than glossed.
View treatmentRepair & Recovery Stack
CompoundedThree recovery peptides in one protocol, with each component's evidence described separately.
View treatmentSermorelin ODT
CompoundedThe needle-free route to sermorelin — offered honestly, including what we can't tell you about it.
View treatmentProducts marked Compounded are prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved and are not equivalent to or interchangeable with any branded product.
An honest word on the evidence
This is the page where being straight matters most. The great majority of what is known about BPC-157 comes from animal work; the human record is thin, and popularity has run a long way ahead of proof. These peptides sit in an unsettled regulatory position. In April 2026 the FDA removed twelve peptide substances from Category 2 of its interim 503A bulk substances list, this one among them — a step that followed the nominators withdrawing their nominations rather than any safety finding, and one that does not by itself authorize compounding. In July 2026 the Pharmacy Compounding Advisory Committee voted on whether seven of them should be added to the 503A Bulks List. That vote is a recommendation, not a decision: formal addition requires notice-and-comment rulemaking, which has not completed. Nothing here is FDA-approved for any use. We prescribe it only where a clinician judges it appropriate, we monitor it, and if nothing is moving we stop.
Frequently asked questions
No. It is not approved for any use. It is prepared by a licensed compounding pharmacy under a prescription, and the rules governing that are themselves being revisited — see the regulatory position.
Largely preclinical. The animal work is genuinely interesting and the human work is limited, small and mostly old. What the human evidence shows sets out what exists rather than what is claimed.
It is explored for that, and the gut is where the preclinical support is strongest — which is not the same as an approved indication. See BPC-157 and gut health.
That is a clinical decision made with your prescriber, and it is not something this page sets out.
No one can tell you that, and anyone who does is guessing. It is explored as support alongside the things that actually rebuild tissue — loading, sleep, protein and time.
See if BPC-157 fits your plan
The right plan begins with knowing where you are. Start with a short eligibility check and a baseline — and we'll tell you, honestly, what fits.
We measure first. Then we act.
ACT 2 Health provides clinician-led care. Treatments described are available only to eligible patients following clinical evaluation and within applicable regulations. This page is educational and is not medical advice. Individual results vary.